2025-03-26 20:47:16
Latest Post
NBCC India Ltd signs MoU with MAHAPREIT
Switch considers potential ceasing of UK manufacturing operations, Will double-down on India EV market
Quadrant Future Tek Ltd receives LOA from RailTel Corporation of India Ltd
NCLT approves resolution plan by Deep Diamond India Ltd for Oasis Ceramics Pvt Ltd
ITCONS E-Solutions Limited secures order worth Rs. 51.36 lakhs
Stock Report
Nectar Lifesciences Ltd Q4 FY2024 consolidated profit at Rs. 59.20 lakhs
Posted On : 2024-05-15 21:12:22( TIMEZONE : IST )
Nectar Lifesciences Limited has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 442.8427 crores during the period ended March 31, 2024 as compared to Rs. 452.6513 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 0.5920 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 1.5669 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.03 for the period ended March 31, 2024 as compared to Rs. 0.07 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 442.8427 crs | ₹452.6513 crs |  -2.17% |
| Net Profit | ₹0.5920 crs | ₹1.5669 crs | -62.22% |
| EPS | ₹0.03 | ₹0.07 | -57.14% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 442.8427 crores during the period ended March 31, 2024 as compared to Rs.406.7385 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.5920 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.3.6768 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.03 for the period ended March 31, 2024 as compared to Rs.0.16 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 442.8427 crs | ₹406.7385 crs |  8.88% |
| Net Profit | ₹0.5920 crs | ₹3.6768 crs | -83.90% |
| EPS | ₹0.03 | ₹0.16 | -81.25% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.1698.6613 crores during the Financial Year ended March 31, 2024 as compared to Rs.1566.8482 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.4.9946 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.-24.1829 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.0.22 for the Financial Year ended March 31, 2024 as compared to Rs.-1.08 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹1698.6613 crs | ₹1566.8482 crs | 8.41% |
| Net Profit | ₹4.9946 crs | ₹-24.1829 crs | 120.65% |
| EPS | ₹0.22 | ₹-1.08 | 120.37% |
Shares of Nectar Lifesciences Limited was last trading in BSE at Rs. 32.82 as compared to the previous close of Rs. 33.15. The total number of shares traded during the day was 46711 in over 341 trades.
The stock hit an intraday high of Rs. 33.45 and intraday low of 32.61. The net turnover during the day was Rs. 1542596.00.
